Thrombomodulin: Its Expression and Releace into the Circulation

  • Nobuo Aoki
  • Shin-ichi Ohdama
  • Kazunori Hirokawa
Conference paper


Thrombomodulin(TM), is an endothelial cell surface glycoprotein that plays an important role in thromboresistance especially in microvasuculature. It forms a one to one complex with thrombin to inactivate its procoagulant property. This complex catalyzes activation of protein C and activated protein C inactivates coagulant factors Va and VIIIa in the presence of protein S. Thus, TM converts procoagulant thrombin to an anticoagulant and plays a central role in the protein C anticoagulant pathway. The physiological importance of the TM-protein C system in the prevention of thrombus formation is supported by various observations including thrombotic tendencies in patients with congenital deficiency of protein C and effective prevention of experimental thrombosis by intravenous administration of purified TM. Previous studies have shown that TM on endothelial cells is down-regulated by endotoxin, TNF or IL-1β. This loss of anticoagulant potential together with induction of tissue factor in blood coagulation by these agents is thought to be related to the hypercoagulative state of sepsis, chronic inflamation and cancer. Therefore, states of expression of TM on surfaces of endothelial cells are important in regulation of intravascular coagulation.


Retinoic Acid Phorbol Myristate Acetate Phorbol Ester Phorbol Myristate Acetate Endothelial Cell Surface 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hirokawa K, Aoki N (1990) Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. J Biochem 108: 839–845PubMedGoogle Scholar
  2. 2.
    Hirokawa K, Aoki N (1991) Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J Cell Physiol 147: 157–165PubMedCrossRefGoogle Scholar
  3. 3.
    Hirokawa K, Aoki N (1991) Up-regulation of thrombomodulin by activation of histamine Hi-receptors in human umbilical-vein endothelial cells in vitro. Biochem J 276: 739–743PubMedGoogle Scholar
  4. 4.
    Ohdama S, Takano S, Ohashi K, Miyake S, Aoki N (1991) Pentoxifylline prevents tumor necrosis factor-induced suppression of endothelial cell surface thrombomodulin. Thromb Res 62: 745–755PubMedCrossRefGoogle Scholar
  5. 5.
    Miyake S, Ohdama S, Tazawa R, Aoki N (1992) Retinoic acid prevents cytokine-induced suppression of thrombomodulin expression on surface of human vascular endtothelial cells in vitro. Thromb Res in pressGoogle Scholar
  6. 6.
    Takano S, Kimura S, Ohdama S, Aoki N (1990) Plasma thrombomodulin in health and diseases. Blood 76: 2024–2029PubMedGoogle Scholar

Copyright information

© Springer Japan 1993

Authors and Affiliations

  • Nobuo Aoki
    • 1
  • Shin-ichi Ohdama
    • 1
  • Kazunori Hirokawa
    • 1
  1. 1.The First Department of MedicineTokyo Medical and Dental UniversityYushima, Bunkyo-Ku, Tokyo 113Japan

Personalised recommendations